Building an evidentiary case for circulating ghbp as a biomarker for drug-associated stunting of growth
Ended Project Grant Awarded Last action
- Award ID
- R41HD094622
- Recipient
-
Reveragen Biopharma, Inc. UEI NQA4J3L3E1Z4
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,998
Award facts
- Assistance listing
- 93.865 Child Health and Human Development Extramural Research
- Completion date
- Originally
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,998 |
Quick answers
Who received award R41HD094622?
R41HD094622 was awarded to Reveragen Biopharma, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on July 1, 2018.
How much is award R41HD094622 worth?
$224,998 has been obligated on R41HD094622.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award